Bayer, Johnson and Johnson's heart drug Xarelto fails trial to widen use Ruby Khatun Khatun28 Aug 2018 9:45 AM ISTFRANKFURT: Bayer and Johnson and Johnson's campaign to widen the market for its heart drug Xarelto hit a snag on Sunday when a study for a potential...
NPPA notifies prices of 65 essential formulations Ruby Khatun Khatun19 Dec 2017 5:11 PM ISTNew Delhi: National drug pricing regulator NPPA said it has notified prices of 65 essential formulations, including those used for the treatment of...
Lupin gets USFDA nod to market anti-infections tablets Ruby Khatun Khatun12 Sept 2017 10:21 AM ISTNew Delhi: Drug firm Lupin has received approval from the US health regulator to market its generic Doxycycline hyclate tablets, used for the...